<DOC>
	<DOCNO>NCT00766662</DOCNO>
	<brief_summary>Studies show Intermittent preventive treatment infant ( IPTi ) Sulfadoxine-pyrimethamine ( SP ) reduce incidence clinical malaria anemia without modify infant ' serological response EPI vaccine . Thus IPTi see potential public health tool great benefit child Africa logical addition Immunization Plus package . The objective operational researcher - develop implementation model IPTi health care system Mali - assess impact EPI vaccines health intervention coverage - molecular maker resistance SP</brief_summary>
	<brief_title>Intermittent Preventive Treatment Infant Mali</brief_title>
	<detailed_description>The study implement district region Koulikoro ; district Koulikoro district Kolokani . The whole district Koulikoro cover intervention Kolokani , 22 health area ( sub district ) randomize 1:1 ratio intervention 11 health area 11 serve control assessment impact IPTi implementation EPI vaccines health intervention coverage well impact resistance SP . The implementation consist administration Â½ tablet Sulfadoxine -Pyrimethamine EPI vaccine ( DTP2 , DTP3 Measles vaccine ) December 2006 December 2007 .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Resident Kolokani , Mali Age less 24 month Not Resident Kolokani Age 24 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Intermittent Preventive Treatment</keyword>
	<keyword>EPI vaccine coverage</keyword>
	<keyword>Resistance P. falciparum Sulfadoxine- Pyrimethamine</keyword>
</DOC>